Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI, Rajkumar SV.
Ann Intern Med. 2022 Dec;175(12):ITC177-ITC192. doi: 10.7326/AITC202212200. Epub 2022 Dec 13.
Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
Kaur J, Valisekka SS, Hameed M, Bandi PS, Varma S, Onwughalu CJ, Ibrahim H, Mongia H.
Clin Lymphoma Myeloma Leuk. 2023 May;23(5):e195-e212. doi: 10.1016/j.clml.2023.02.004. Epub 2023 Feb 23.
When a Monoclonal Gammopathy Is Not Multiple Myeloma.
Derman B, Castillo JJ, Sarosiek S, Beksac M.
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10. doi: 10.1200/EDBK_349643.
Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
Amaador K, Peeters H, Minnema MC, Nguyen TQ, Dendooven A, Vos JMI, Croockewit AJ, van de Donk NWCJ, Jacobs JFM, Wetzels JFM, Sprangers B, Abrahams AC.
Neth J Med. 2019 Sep;77(7):243-254.
Cutaneous manifestations of monoclonal gammopathy.
Claveau JS, Wetter DA, Kumar S.
Blood Cancer J. 2022 Apr 11;12(4):58. doi: 10.1038/s41408-022-00661-1.
Monoclonal gammopathy of uncertain significance.
Alejo E, Puertas B, Mateos MV.
Med Clin (Barc). 2023 Sep 8;161(5):217-224. doi: 10.1016/j.medcli.2023.05.006. Epub 2023 Jun 15.
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA; International Kidney and Monoclonal Gammopathy Research Group.
Blood. 2012 Nov 22;120(22):4292-5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9.
Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S, Haidous M, Dalle IA, Dendooven A, Moukalled N, Van Craenenbroeck A, Bazarbachi A, Sprangers B.
Crit Rev Oncol Hematol. 2023 Mar;183:103926. doi: 10.1016/j.critrevonc.2023.103926. Epub 2023 Feb 2.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M; International Myeloma Working Group.
Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22.
[Monoclonal gammopathy of (un)known significance].
Steinhardt M, Kortüm M, Einsele H, Rasche L.
Dtsch Med Wochenschr. 2022 Jun;147(11):675-682. doi: 10.1055/a-1664-7353. Epub 2022 May 30.
